Venus, Medtech

Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.

Veröffentlicht: 07.08.2025 um 18:08 Uhr, prnewswire.co.uk

Venus Medtech (Hangzhou) Inc. Denmark Finland Germany Netherlands Sweden United Kingdom China

en | boerse | 67926753 |